Advanced search
Publication Cover
International Journal of Nephrology and Renovascular Disease Volume 6, 2013 - Issue
Submit an article Journal homepage
55
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Urinary angiotensinogen is a marker for tubular injuries in patients with type 2 diabetes

Takahiro Terami1 Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
,
Jun Wada1 Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, JapanCorrespondence[email protected]
,
Kentaro Inoue1 Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
,
Atsuko Nakatsuka1 Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan;2 Department of Diabetic Nephropathy, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
,
Daisuke Ogawa1 Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan;2 Department of Diabetic Nephropathy, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
,
Sanae Teshigawara1 Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
,
Kazutoshi Murakami1 Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan;3 Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
,
Akihiro Katayama1 Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
,
Jun Eguchi1 Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
&
Hirofumi Makino1 Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
 show all
Pages 233-240 | Published online: 22 Oct 2013

References

  • RoksnoerLCVerdonkKvan den MeirackerAHHoornEJZietseRDanserAHUrinary markers of intrarenal renin–angiotensin system activity in vivoCurr Hypertens Rep2013152818823296471
  • SawaguchiMArakiSIKoboriHAssociation between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitusJ Diabetes Investig201233318324
  • InoueKWadaJEguchiJUrinary Fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarrayPLoS ONE
  • KoboriHNangakuMNavarLGNishiyamaAThe intrarenal renin–angiotensin system: from physiology to the pathobiology of hypertension and kidney diseasePharmacol Rev200759325128717878513
  • van KatsJPSchalekampMAVerdouwPDDunckerDJDanserAHIntrarenal angiotensin II: interstitial and cellular levels and site of productionKidney Int20016062311231711737604
  • KamiyamaMZsombokAKoboriHUrinary angiotensinogen as a novel early biomarker of intrarenal renin–angiotensin system activation in experimental type 1 diabetesJ Pharmacol Sci2012119431432322850612
  • KoboriHAlperABShenavaRUrinary angiotensinogen as a novel biomarker of the intrarenal renin–angiotensin system status in hypertensive patientsHypertension200953234435019075095
  • MillsKTKoboriHHammLLIncreased urinary excretion of angiotensinogen is associated with risk of chronic kidney diseaseNephrol Dial Transplant20122783176318122399491
  • van den HeuvelMBatenburgWWJainandunsingSUrinary renin, but not angiotensinogen or aldosterone, reflects the renal renin–angiotensin-aldosterone system activity and the efficacy of renin–angiotensin-aldosterone system blockade in the kidneyJ Hypertens201129112147215521941204
  • HongCYHughesKChiaKSNgVLingSLUrinary alpha1-microglobulin as a marker of nephropathy in type 2 diabetic Asian subjects in SingaporeDiabetes Care200326233834212547859
  • KorpinenETeppoAMHukkanenLAkerblomHKGrönhagen-RiskaCVaaralaOUrinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetesDiabetes Care200023566466810834427
  • PfleidererSZimmerhacklLBKinneRManzFSchulerGBrandisMRenal proximal and distal tubular function is attenuated in diabetes mel-litus type 1 as determined by the renal excretion of alpha 1-microglobulin and Tamm-Horsfall proteinClin Investig19937112972977
  • PetricaLPetricaMVladANephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trialWien Klin Wochenschr200912123–2476577520047115
  • PetricaLPetricaMVladAProximal tubule dysfunction is dissociated from endothelial dysfunction in normoalbuminuric patients with type 2 diabetes mellitus: a cross-sectional studyNephron Clin Pract20111182c155c16421150223
  • RichouxJPCordonnierJLBouhnikJImmunocytochemical localization of angiotensinogen in rat liver and kidneyCell Tissue Res198323324394516616576
  • SaitoTUrushiharaMKotaniYKagamiSKoboriHIncreased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetesAm J Med Sci2009338647848019884815
  • YamamotoTNakagawaTSuzukiHUrinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney diseaseJ Am Soc Nephrol20071851558156517409316
  • NishiyamaAKonishiYOhashiNUrinary angiotensinogen reflects the activity of intrarenal renin–angiotensin system in patients with IgA nephropathyNephrol Dial Transplant201126117017720615910
  • UrushiharaMKondoSKagamiSKoboriHUrinary angiotensinogen accurately reflects intrarenal Renin–angiotensin system activityAm J Nephrol201031431832520160435
  • OgawaSKoboriHOhashiNAngiotensin II type 1 receptor blockers reduce urinary angiotensinogen excretion and the levels of urinary markers of oxidative stress and inflammation in patients with type 2 diabetic nephropathyBiomark Insights200949710219652765

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.